echoloc
Company profile

Rhythm Pharmaceuticals Inc. Tech Stack

Commercial-stage biopharma developing precision therapies for rare MC4R pathway diseases

Biotechnology Research Boston, MA 201–500 employees Founded 2008 Public Company

Rhythm Pharmaceuticals is a Boston-based, commercial-stage biopharma focused on rare neuroendocrine and MC4R pathway diseases. Hiring is accelerating and skews senior and director-level, led by sales and field healthcare roles across the US, Europe and Canada, which points to commercial launch expansion over early research. A stack of Veeva RIM, Veeva QualityDocs and SAS alongside Snowflake and Power BI reflects regulated multi-country operations paired with a modern analytics layer.

Tech Stack 21 technologies

Core StackADP SAS Smartsheet Salesforce Snowflake Power BI Python AWS WordPress SAS/GRAPH Ironclad Coupa E*TRADE Veeva RIM ADP Workforce Now Concur GCP WP Engine Azure SSL/TLS Veeva QualityDocs

What Rhythm Pharmaceuticals Inc. Is BuildingChallenges and projects from their job posts

◆Challenges

  • Ensuring regulatory compliance across multiple countries
  • Driving market growth in Germany and complex markets
  • Improving patient medication adherence
  • Optimizing patient referral pathways
  • Improving statistical programming quality
  • Recruiting key commercial and medical talent

▲Active Projects

  • Clinical trials in rare disease programs
  • Real-world evidence initiatives
  • Expanding patient support and comprehensive care programs
  • Local genetic testing initiatives
  • Medical education meetings, conferences and webinars

Hiring Activity

Accelerating50 roles · 25 in 30d

Department

Sales
13
Healthcare
11
Data
3
HR
3
Operations
3
Research
3
Finance
2
Manufacturing
2

Seniority

Senior
26
Director
11
Lead
6
Manager
4
Mid
1

Notable leadership hires: Medical Director, Head of Strategic Sourcing

Companies like Rhythm Pharmaceuticals Inc.

100+ Biotechnology Research companies running SAS and Python

See the full list

About Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals is a public biopharmaceutical company founded in 2008 and headquartered in Boston, Massachusetts, with 201–500 employees. It develops and commercializes precision medicines for rare neuroendocrine diseases, with its lead asset marketed in North America, Europe and other regions. The pipeline includes clinical programs in rare MC4R pathway diseases, investigational MC4R agonists, and preclinical small molecules for congenital hyperinsulinism. The company serves healthcare providers, patients and families, supported by patient programs and medical education. It is hiring across the United States, Canada, the United Kingdom, Germany, the Netherlands, Switzerland and Peru.

HeadquartersBoston, MA
Company Size201–500 employees
Founded2008
Hiring MarketsUnited States, Peru, Netherlands, Switzerland, Germany, United Kingdom, Canada

Frequently Asked Questions

What tech stack does Rhythm Pharmaceuticals use?

Rhythm uses Veeva RIM and Veeva QualityDocs for regulatory and quality, SAS and Python for analysis, Snowflake and Power BI for data, Salesforce for CRM, plus Coupa, Concur, Ironclad, ADP and AWS, Azure and GCP.

Is Rhythm Pharmaceuticals hiring sales roles?

Yes. Sales is the largest hiring area, followed by field healthcare roles, with an accelerating pace and a senior- and director-heavy mix including Medical Director and Head of Strategic Sourcing positions.

What countries does Rhythm Pharmaceuticals hire in?

Rhythm hires in the United States, Canada, the United Kingdom, Germany, the Netherlands, Switzerland and Peru, consistent with commercializing its lead asset across North America and Europe.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size

How this profile is built

Rhythm Pharmaceuticals Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.